EUFOREA consensus on biologics for CRSwNP with or without asthma

Fokkens, WJ; Lund, V; Bachert, C; Mullol, J; Bjermer, L; Bousquet, J; Canonica, GW; Deneyer, L; Desrosiers, M; Diamant, Z; Han, J; Heffler, E; Hopkins, C; Jankowski, R; Joos, G; Knill, A; Lee, J; Lee, SE; Marien, G; Pugin, B; Senior, B; Seys, SF; Hel

Fokkens, WJ (reprint author), Amsterdam Univ Med Ctr, Dept Otorhinolaryngol, Locat AMC, Meibergdreef 9, NL-1100 AD Amsterdam, Netherlands.

ALLERGY, 0; ():

Abstract

Novel therapies such as type 2 targeting biologics are emerging treatment options for patients with chronic inflammatory respiratory diseases, fulfill......

Full Text Link